197 related articles for article (PubMed ID: 27365127)
1. Exploring the Transition of Human α-Synuclein from Native to the Fibrillar State: Insights into the Pathogenesis of Parkinson's Disease.
Fazili NA; Naeem A
J Fluoresc; 2016 Sep; 26(5):1659-69. PubMed ID: 27365127
[TBL] [Abstract][Full Text] [Related]
2. Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease.
Fazili NA; Naeem A
Biochimie; 2015 Jan; 108():178-85. PubMed ID: 25461276
[TBL] [Abstract][Full Text] [Related]
3. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
Zaidi FK; Deep S
Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
[TBL] [Abstract][Full Text] [Related]
4. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction.
Zhu M; H Patel S; Han S
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770
[TBL] [Abstract][Full Text] [Related]
5. Α-synuclein misfolding and Parkinson's disease.
Breydo L; Wu JW; Uversky VN
Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
[TBL] [Abstract][Full Text] [Related]
6. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.
Uversky VN; Eliezer D
Curr Protein Pept Sci; 2009 Oct; 10(5):483-99. PubMed ID: 19538146
[TBL] [Abstract][Full Text] [Related]
7. Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease.
Uversky VN; Li J; Fink AL
FEBS Lett; 2001 Jul; 500(3):105-8. PubMed ID: 11445065
[TBL] [Abstract][Full Text] [Related]
8. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
Galvagnion C; Buell AK
Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
[No Abstract] [Full Text] [Related]
9. Structural and Aggregation Properties of Alpha-Synuclein Linked to Phospholipase A2 Action.
Broersen K; Ruiperez V; Davletov B
Protein Pept Lett; 2018; 25(4):368-378. PubMed ID: 29577851
[TBL] [Abstract][Full Text] [Related]
10. The aggregation and fibrillation of alpha-synuclein.
Fink AL
Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to counter protein aggregation pathology in Parkinson's disease.
Stott SRW; Wyse RK; Brundin P
Prog Brain Res; 2020; 252():451-492. PubMed ID: 32247372
[TBL] [Abstract][Full Text] [Related]
12. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
Li HT; Du HN; Tang L; Hu J; Hu HY
Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
[TBL] [Abstract][Full Text] [Related]
13. Raised calcium promotes α-synuclein aggregate formation.
Nath S; Goodwin J; Engelborghs Y; Pountney DL
Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
[TBL] [Abstract][Full Text] [Related]
14. Vitamin B12 inhibits α-synuclein fibrillogenesis and protects against amyloid-induced cytotoxicity.
Jia L; Wang Y; Wei W; Zhao W; Lu F; Liu F
Food Funct; 2019 May; 10(5):2861-2870. PubMed ID: 31070198
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein aggregation nucleates through liquid-liquid phase separation.
Ray S; Singh N; Kumar R; Patel K; Pandey S; Datta D; Mahato J; Panigrahi R; Navalkar A; Mehra S; Gadhe L; Chatterjee D; Sawner AS; Maiti S; Bhatia S; Gerez JA; Chowdhury A; Kumar A; Padinhateeri R; Riek R; Krishnamoorthy G; Maji SK
Nat Chem; 2020 Aug; 12(8):705-716. PubMed ID: 32514159
[TBL] [Abstract][Full Text] [Related]
16. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
[TBL] [Abstract][Full Text] [Related]
17. PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson's disease-related protein.
Rekas A; Lo V; Gadd GE; Cappai R; Yun SI
Macromol Biosci; 2009 Mar; 9(3):230-8. PubMed ID: 19116892
[TBL] [Abstract][Full Text] [Related]
18. The Interaction of Alpha-synuclein with Membranes and its Implication in Parkinson's Disease: A Literature Review.
Gonzalez-Horta A
Nat Prod Commun; 2015 Oct; 10(10):1775-8. PubMed ID: 26669123
[TBL] [Abstract][Full Text] [Related]
19. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
Lee SJ
Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
Tavassoly O; Lee JS
FEBS Lett; 2012 Sep; 586(19):3222-8. PubMed ID: 22771474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
